Palvella Therapeutics PVLA
NASDAQ PVLA
$166.26 -2.45 (-1.45%)
As of: Nov 11, 2026 · 12:59 PM EST

Palvella Therapeutics (PVLA) Return on Assets [ROA] (2014 - 2026)

Updated

Palvella Therapeutics (PVLA) posted Return on Assets [ROA] of -23.85% for Q2 2026, up 13.20 percentage points from -37.06% a year earlier and up 6.64 percentage points from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Palvella Therapeutics' Return on Assets [ROA] came in at -56.45%, down 20.05 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -26.20 percentage points (FY2020 to FY2025).
  • In prior years, Palvella Therapeutics' Return on Assets [ROA] was -36.40% in FY2024 (-72.68 pp), 36.28% in FY2023 (+71.19 pp), -34.91% in FY2022 (+0.47 pp) and -35.38% in FY2021 (-5.12 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q3 2024.
  • On a year-over-year basis, Return on Assets [ROA] increased in three of the last eight quarters, with an average year-over-year change of -8.60 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2024, with a gain of 63.95 percentage points; the weakest was Q3 2025, with a drop of 46.42 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -30.49% (Q1 2026), -65.95% (Q4 2025) and -46.85% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Palvella Therapeutics 2.47 Bn 2.23 Bn - -30.45%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -30.45%
Jun 30, 2026 -23.78%
Mar 31, 2026 -30.43%
Dec 31, 2025 -65.83%
Sep 30, 2025 -45.87%
Jun 30, 2025 -36.69%
Mar 31, 2025 -27.31%
Dec 31, 2024 -32.06%
Sep 30, 2024 104.86%
Jun 30, 2024 73.00%
Mar 31, 2024 154.08%
Dec 31, 2023 53.54%
Sep 30, 2023 -39.37%
Jun 30, 2023 -32.75%
Mar 31, 2023 -48.09%
Dec 31, 2022 -35.30%
Sep 30, 2022 -32.60%
Jun 30, 2022 -32.71%
Mar 31, 2022 -31.59%
Dec 31, 2021 -28.08%
API Access

Palvella Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PVLA&period=max&api_key=YOUR_API_KEY